Table 6.
Summary statistics of semen parameters, SDF, and ORP before and after the treatment of unexplained male infertility patients with FH PRO for Men.
| Parameters | Before Treatment (n = 29) |
After Treatment (n = 29) |
Percent Change (Mean ± SEM) |
p Value Wilcoxon Test |
|---|---|---|---|---|
| Semen volume (mL) | 3.0 ± 1.2 (3.0; 2.0–4.0) |
3.1 ± 1.2 (3.0; 2.0–4.0) |
13.6 ± 8.8 | 0.4852 |
| Sperm concentration (106/mL) | 46.2 ± 34.3 (36.0; 24.3–53.3) |
51.5 ± 28.9 (52.0; 29.5–65.2) |
29.4 ± 12.4 | 0.1872 |
| Total motility (%) | 52.5 ± 8.3 (50.0; 45.0–60.0) |
52.2 ± 9.7 (52.0; 45.0–60.5) |
0.6 ± 3.7 | 0.6495 |
| Progressive motility (%) | 10.9 ± 9.9 (10; 0.0–20.0) |
17.9 ± 11.5 (15.0; 10.0–32.0) |
46.3 ± 15.2 | 0.0024 |
| Normal morphology (%) | 5.7 ± 2.5 (4.0; 4.0–7.0) |
6.7 ± 3.0 (6.0; 4.0–9.3) |
31.4 ± 13.9 | 0.1779 |
| SDF (%) | 28.2 ± 17.5 (21.0; 14.5–47.3) |
23.0 ± 11.6 (20.0; 15.8–28.3) |
−5.9 ± 8.3 | 0.0306 |
| ORP (mV/106 sperm/mL) | 1.6 ± 1.1 (1.3; 0.8–2.3) |
1.1 ± 0.9 (0.9; 0.5–1.4) |
−19.6 ± 11.7 | 0.0168 |
All the values are presented as mean ± SD (median; interquartile range). SDF: sperm DNA fragmentation, ORP: oxidation-reduction potential.